Intramolecular epitope spreading in Heymann nephritis

Journal of the American Society of Nephrology

Volumn 18, Issue 12, 2007, Pages 3060-3066

  Shah, Pallavi ^a   Tramontano, Alfonso ^a   Makker, Sudesh P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; EPITOPE; MEGALIN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEYMANN NEPHRITIS; IMMUNE RESPONSE; IMMUNIZATION; IN VIVO STUDY; LIGAND BINDING; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA; RAT; WESTERN BLOTTING;

EID: 35948993564     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2007030342     Document Type: Article

References (43)

1. Raychowdhury R, Niles JL, McCluskey RT, Smith JA: Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor. Science 244: 1163-1165, 1989
2. Kerjaschki D, Miettinen A, Farquhar MG: Initial events in the formation of immune deposits in passive Heymann nephritis: gp330-anti-gp330 immune complexes form in epithelial coated pits and rapidly become attached to the glomerular basement membrane. J Exp Med 166: 109-128, 1987
3. Kanalas JJ, Makker SP: Isolation of a 330-kDa glycoprotein from human kidney similar to the Heymann nephritis autoantigen (gp330). J Am Soc Nephrol 1: 792-798, 1990
4. Quiza CG, Leenaerts PL, Hall BM: The role of T cells in the mediation of glomerular injury in Heymann's nephritis in the rat. Int Immunol 4: 423-432, 1992
5. Penny MJ, Boyd RA, Hall BM: Role of T cells in the mediation of Heymann nephritis: II - Identification of Th1 and cytotoxic cells in glomeruli. Kidney Int 51: 1059-1068, 1997
6. Walters G, Wu H, Knight JF: Glomerular T cells in Heymann nephritis. Clin Exp Immunol 126: 319-325, 2001
7. Debiec H, Nauta J, Coulet F, van der Burg M, Guigonis V, Schurmans T, de Heer E, Soubrier F, Janssen F, Ronco P: Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies. Lancet 364: 1252-1259, 2004
8. Argraves WS: Members of the low density lipoprotein receptor family control diverse physiological processes. Front Biosci 6: D406-D416, 2001
9. Orlando RA, Exner M, Czekay RP, Yamazaki H, Saito A, Ullrich R, Kerjaschki D, Farquhar MG: Identification of the second cluster of ligand-binding repeats in megalin as a site for receptor-ligand interactions. Proc Natl Acad Sci USA 94: 2368-2373, 1997
10. Christensen EI, Birn H: Megalin and cubilin: multifunctional endocytic receptors. Nat Rev Mol Cell Biol 3: 256-266, 2002
11. Saito A, Yamazaki H, Rader K, Nakatani A, Ullrich R, Kerjaschki D, Orlando RA, Farquhar MG: Mapping rat megalin: The second cluster of ligand binding repeats contains a 46-amino acid pathogenic epitope involved in the formation of immune deposits in Heymann nephritis. Proc Natl Acad Sci U S A 93: 8601-8605, 1996
12. Kerjaschki D, Exner M, Ullrich R, Susani M, Curtiss LK, Witztum JL, Farquhar MG, Orlando RA: Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis. J Clin Invest 100: 2303-2309, 1997
13. Raychowdhury R, Zheng G, Brown D, McCluskey RT: Induction of Heymann nephritis with a gp330/megalin fusion protein. Am J Pathol 148: 1613-1623, 1996
14. Yamazaki H, Ullrich R, Exner M, Saito A, Orlando RA, Kerjaschki D, Farquhar MG: All four putative ligand-binding domains in megalin contain pathogenic epitopes capable of inducing passive Heymann nephritis. J Am Soc Nephrol 9: 1638-1644, 1998
15. Oleinikov AV, Feliz BJ, Makker SP: A small N-terminal 60-kD fragment of gp600 (megalin), the major autoantigen of active Heymann nephritis, can induce a full-blown disease. J Am Soc Nephrol 11: 57-64, 2000
16. Tramontano A, Makker SP: Conformation and glycosylation of a megalin fragment correlate with nephritogenicity in Heymann nephritis. J Immunol 172: 2367-2373, 2004
17. Tramontano A, Knight T, Vizzuso D, Makker SP: Nested N-terminal megalin fragments induce high-titer autoantibody and attenuated Heymann nephritis. J Am Soc Nephrol 17: 1979-1985, 2006
18. Scofield RH, Pierce PG, James JA, Kaufman KM, Kurien BT: Immunization with peptides from 60 kDa Ro in diverse mouse strains. Scand J Immunol 56: 477-483, 2002
19. Deshmukh US, Kannapell CC, Fu SM: Immune responses to small nuclear ribonucleoproteins: Antigen-dependent distinct B cell epitope spreading patterns in mice immunized with recombinant polypeptides of small nuclear ribonucleoproteins. J Immunol 168: 5326-5332, 2002
20. McCluskey J, Farris AD, Keech CL, Purcell AW, Rischmueller M, Kinoshita G, Reynolds P, Gordon TP: Determinant spreading: Lessons from animal models and human disease. Immunol Rev 164: 209-229, 1998
21. Thrasyvoulides A, Lymberi P: Evidence for intramolecular B-cell epitope spreading during experimental immunization with an immunogenic thyroglobulin peptide. Clin Exp Immunol 132: 401-407, 2003
22. Bolton WK, Chen L, Hellmark T, Wieslander J, Fox JW: Epitope spreading and autoimmune glomerulonephritis in rats induced by a T cell epitope of Goodpasture's antigen. J Am Soc Nephrol 16: 2657-2666, 2005
23. Krebs P, Kurrer MO, Kremer M, De Giuli R, Sonderegger I, Henke A, Maier R, Ludewig B: Molecular mapping of autoimmune B cell responses in experimental myocarditis. J Autoimmun 28: 224-233, 2007
24. Li N, Aoki V, Hans-Filho G, Rivitti EA, Diaz LA: The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem). J Exp Med 197: 1501-1510, 2003
25. Ueki A, Isozaki Y, Tomokuni A, Hatayama T, Ueki H, Kusaka M, Shiwa M, Arikuni H, Takeshita T, Morimoto K: Intramolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individuals. Clin Exp Immunol 129: 556-561, 2002
26. Salato VK, Hacker-Foegen MK, Lazarova Z, Fairley JA, Lin MS: Role of intramolecular epitope spreading in pemphigus vulgaris. Clin Immunol 116: 54-64, 2005
27. Wu J, Arends J, Borillo J, Zhou C, Merszei J, McMahon J, Lou YH: A self T cell epitope induces autoantibody response: mechanism for production of antibodies to diverse glomerular basement membrane antigens. J Immunol 172: 4567-4574, 2004
28. Dean EG, Wilson GR, Li M, Edgtton KL, O'Sullivan KM, Hudson BG, Holdsworth SR, Kitching AR: Experimental autoimmune Goodpasture's disease: A pathogenetic role for both effector cells and antibody in injury. Kidney Int 67: 566-575, 2005
29. Wu J, Hicks J, Ou C, Singleton D, Borillo J, Lou YH: Glomerulonephritis induced by recombinant collagen IV alpha 3 chain noncollagen domain 1 is not associated with glomerular basement membrane antibody: A potential T cell-mediated mechanism. J Immunol 167: 2388-2395, 2001
30. Makker SP, Tramontano A: Differential capacity of anti-RAP and antimegalin antibodies to produce progressive passive Heymann nephritis: Implications for the pathogenesis of idiopathic human membranous glomerulonephritis. J Pathol 210: 282-287, 2006
31. Allegri L, Brianti E, Chatelet F, Manara GC, Ronco P, Verroust P: Polyvalent antigen-antibody interactions are required for the formation of electron-dense immune deposits in passive Heymann's nephritis. Am J Pathol 125: 1-6, 1986
32. Bhan AK, Schneeberger EE, Baird LG, Collins AB, Kamata K, Bradford D, Erikson ME, McCluskey RT: Studies with monoclonal antibodies against brush border antigens in Heymann nephritis. Lab Invest 53: 421-432, 1985
33. Dekan G, Miettinen A, Schnabel E, Farquhar MG: Binding of monoclonal antibodies to glomerular endothelium, slit membranes, and epithelium after in vivo injection: Localization of antigens and bound IgGs by immunoelectron microscopy. Am J Pathol 137:913-927, 1990
34. James JA, Gross T, Scofield RH, Harley JB: Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B′-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med 181: 453-461, 1995
35. Monneaux F, Muller S: Epitope spreading in systemic lupus erythematosus: Identification of triggering peptide sequences. Arthritis Rheum 46: 1430-1438, 2002
36. Schlosser M, Banga JP, Madec AM, Binder KA, Strebelow M, Rjasanowski I, Wassmuth R, Gilliam LK, Luo D, Hampe CS: Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes. Diabetologia 48: 922-930, 2005
37. Jaume JC, Parry SL, Madec AM, Sonderstrup G, Baekkeskov S: Suppressive effect of glutamic acid decarboxylase 65-specific autoimmune B lymphocytes on processing of T cell determinants located within the antibody epitope. J Immunol 169: 665-672, 2002
38. Mamula MJ: Epitope spreading: The role of self peptides and autoantigen processing by B lymphocytes. Immunol Rev 164: 231-239, 1998
39. Feferman T, Im SH, Fuchs S, Souroujon MC: Breakage of tolerance to hidden cytoplasmic epitopes of the acetylcholine receptor in experimental autoimmune myasthenia gravis. J Neuroimmunol 140: 153-158, 2003
40. Robertson J, Wu J, Arends J, Zhou C, McMahon J, Torres L, Lou YH: Activation of glomerular basement membrane-specific B cells in the renal draining lymph node after T cell-mediated glomerular injury. J Am Soc Nephrol 16: 3256-3263, 2005
41. Kanalas JJ, Makker SP: A possible ligand of serum origin for the kidney autoantigen of Heymann nephritis. J Immunol 141: 4152-4157, 1988
42. Makker SP, Singh AK: Characterization of the antigen (gp600) of Heymann nephritis. Lab Invest 50: 287-293, 1984
43. Makker SP: Analysis of glomeruli-eluted Gp330 autoantibodies and of Gp330 antigen of Heymann nephritis. J Immunol 151: 6500-6508, 1993